Janine Kimpel

Medical University of Innsbruck

Austria

Research Interests

Explore related searches

Professors in Austria Professors in Immunology Immunology professors in Austria

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (18)

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (8)

Volker Thiel

Professor and Chair Virology

University of Bern

SWITZERLAND

View details

Giada Mattiuzzo

Head of Viral Vaccines

Pharmaceuticals and Medical Devices Agency

UNITED KINGDOM

View details

Reinhard Würzner

Associate Professor

Medical University of Innsbruck

AUSTRIA

View details

Bart L. Haagmans

Principal Investigator / Associate Professor - PhD

Erasmus MC

NETHERLANDS

View details

Wegene Borena

Medical University of Innsbruck

AUSTRIA

View details

Zoltan Banki

Medical University of Innsbruck

AUSTRIA

View details

Derek Smith

Professor of Infectious Disease Informatics

University of Cambridge

UNITED KINGDOM

View details

Annika Rössler

University of Innsbruck

AUSTRIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Janine Kimpel

Research Interests

Explore related searches

Contact this professor

Articles (18)

Durability of Cross-Neutralizing Antibodies 5.5 Months After Bivalent Coronavirus Disease 2019 Vaccine Booster

A Global Collaborative Comparison of SARS-CoV-2 Antigenicity Across 15 Laboratories

Characterizing SARS-CoV-2 neutralization profiles after bivalent boosting using antigenic cartography

No evidence for epitranscriptomic m5C modification of SARS-CoV-2, HIV and MLV viral RNA

Retained avidity despite reduced cross-binding and cross-neutralizing antibody levels to Omicron after SARS-COV-2 wild-type infection or mRNA double vaccination.

B and T Cell Responses to SARS-CoV-2 Vaccination in Kidney and Liver Transplant Recipients with and without Previous COVID-19

Antiviral Potential of Azelastine against Major Respiratory Viruses

Immune response after two doses of the BNT162b2 COVID-19 vaccine and risk of SARS-CoV-2 breakthrough infection in Tyrol, Austria: an open-label, observational phase 4 trial.

Therapeutic Efficacy of a VSV-GP-based Human Papilloma Virus Vaccine in a Murine Cancer Model.

Regimen of Coronavirus Disease 2019 Vaccination Influences Extent and Kinetics of Antibody Avidity

High Prevalence of Undocumented SARS-CoV-2 Infections in the Pediatric Population of the Tyrolean District of Schwaz

Can high COVID-19 vaccination rates in adults help protect unvaccinated children? Evidence from a unique mass vaccination campaign, Schwaz/Austria, March 2021

Six-Month Follow-Up of Immune Responses after a Rapid Mass Vaccination against SARS-CoV-2 with BNT162b2 in the District of Schwaz/Austria

The Anti-Histamine Azelastine, Identified by Computational Drug Repurposing, Inhibits Infection by Major Variants of SARS-CoV-2 in Cell Cultures and Reconstituted Human Nasal Tissue.

Development of a Rapid Live SARS-CoV-2 Neutralization Assay Based on a qPCR Readout.

Neutralization Profile after Recovery from SARS-CoV-2 Omicron Infection

SARS-CoV-2 Omicron Variant Neutralization in Serum from Vaccinated and Convalescent Persons

BA.2 and BA.5 omicron differ immunologically from both BA.1 omicron and pre-omicron variants

Collaborators (8)

Volker Thiel

Giada Mattiuzzo

Reinhard Würzner

Bart L. Haagmans

Wegene Borena

Zoltan Banki

Derek Smith

Annika Rössler

Make your next move.